Skip to main content

Table 5 Tumour localisation and hippocampal dose

From: Hippocampal sparing radiotherapy for glioblastoma patients: a planning study using volumetric modulated arc therapy

  Median (range) p-value
3D-CRT  
Temporal Not temporal
 gEUD (Gy) 34.3 (26.0–48.6) 40.4 (24.3–56.1) NS (p = 0.09)
Parietal Not parietal
 gEUD (Gy) 40.6 (24.3–56.1) 36.0 (26.0–48.0) NS (p = 0.40)
Frontal Not frontal
 gEUD (Gy) 38.0 (30.8–48.6) 33.7 (24.3–56.1) NS (p = 0.05)
VMAT   
 Temporal Not temporal
 gEUD (Gy) 19.5 (10.8–43.1) 31.2 (17.9–56.0) p = 0.04
Parietal Not parietal
 gEUD (Gy) 37.9 (25.7–56.0) 21.1 (10.8–43.1) p < 0.01
Frontal Not frontal
 gEUD (Gy) 22.4 (10.8–48.0) 24.1 (10.8–56.0) NS (p = 0.86)